company background image
OMCL logo

Omnicell NasdaqGS:OMCL 株式レポート

最終価格

US$27.91

時価総額

US$1.3b

7D

-4.6%

1Y

-61.1%

更新

17 Jun, 2024

データ

会社財務 +

Omnicell, Inc.

NasdaqGS:OMCL 株式レポート

時価総額:US$1.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

OMCL 株式概要

オムニセル社は、その子会社とともに、米国内外の医療システムや薬局に服薬管理ソリューションや服薬アドヒアランスツールを提供している。

OMCL fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends0/6

報酬

リスク分析

リスクチェックの結果、OMCL 、リスクは検出されなかった。

Omnicell, Inc. 競合他社

価格と性能

Summary of all time highs, changes and price drops for Omnicell
Historical stock prices
Current Share PriceUS$27.91
52 Week HighUS$75.07
52 Week LowUS$25.69
Beta0.84
1 Month Change-8.31%
3 Month Change0.98%
1 Year Change-61.07%
3 Year Change-81.01%
5 Year Change-68.24%
Change since IPO193.48%

最新ニュース

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Jun 16
Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

May 25
Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

Recent updates

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Jun 16
Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

May 25
Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Mar 28
An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 29
Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Feb 23
Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell Is Building A Strong Moat

Feb 22

Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Jan 15
Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Dec 25
Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?

Dec 06
Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?

Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Nov 10
Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?

Sep 06
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?

Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

Aug 08
Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching

Jul 02
Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching

A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)

Jun 08
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)

Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital

Apr 29
Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital

Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

Apr 11
Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?

Mar 23
At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?

Feb 28
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?

Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)

Jan 15
Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)

We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt

Jan 01
We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?

Nov 17
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?

Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers

Nov 03
Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers

Omnicell launches Specialty Pharmacy Services

Oct 11

Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly

Sep 30
Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly

Omnicell says advance services to drive profitable growth in long-run: Investor Day

Sep 20

Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Sep 15
Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger

Aug 31
Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger

Omnicell reports Q2 earnings miss; reaffirms FY22 guidance and issues Q3 outlook

Aug 04

Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?

Aug 03
Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?

Omnicell Fails To Justify Inclusion In Long-Only, Equity-Focused Portfolio

Jul 21

We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease

Jun 27
We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease

Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Jun 13
Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher

May 30
Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher

These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely

May 05
These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely

With EPS Growth And More, Omnicell (NASDAQ:OMCL) Is Interesting

Mar 16
With EPS Growth And More, Omnicell (NASDAQ:OMCL) Is Interesting

What Is Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Doing?

Mar 04
What Is Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Doing?

株主還元

OMCLUS Medical EquipmentUS 市場
7D-4.6%-1.4%1.6%
1Y-61.1%-1.3%21.5%

業界別リターン: OMCL過去 1 年間で-0.9 % の収益を上げたUS Medical Equipment業界を下回りました。

リターン対市場: OMCLは、過去 1 年間で20.8 % のリターンを上げたUS市場を下回りました。

価格変動

Is OMCL's price volatile compared to industry and market?
OMCL volatility
OMCL Average Weekly Movement5.5%
Medical Equipment Industry Average Movement7.7%
Market Average Movement5.7%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

安定した株価: OMCL過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: OMCLの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
19923,590Randy Lippswww.omnicell.com

オムニセル社は、その子会社とともに、米国内外の医療システムや薬局に投薬管理ソリューションやアドヒアランスツールを提供している。同社は、医療システムの患者ケア領域における臨床医のワークフローを改善するPOC(ポイント・オブ・ケア)自動化ソリューション、看護ユニットや病院の他の臨床領域で使用される薬剤や消耗品用のXTシリーズ自動調剤システム、手術室用の特殊自動調剤システム、箱詰めされた薬剤のストックと回収を処理するロボット調剤システムを提供している。また、中央薬局自動化ソリューション、静脈内調剤ロボット、在庫管理ソフトウェアも提供している。さらに、処方箋に基づき、患者ごとに異なる様々な1回分の薬剤ブリスターパッケージを充填し、ラベルを貼る1回分自動化ソリューション、薬剤の自動包装を保証する施設薬局向けの全自動および半自動充填装置、非急性期医療環境における服薬アドヒアランスを高めるための薬剤ブリスターカード包装および包装用品も提供している。さらに、WebベースのソリューションであるEnlivenHealth Patient Engagementを提供している。以前はオムニセル・テクノロジーズ社として知られ、2001年にオムニセル社に社名変更。1992年に法人化され、テキサス州フォートワースに本社を置く。

Omnicell, Inc. 基礎のまとめ

Omnicell の収益と売上を時価総額と比較するとどうか。
OMCL 基礎統計学
時価総額US$1.28b
収益(TTM)-US$21.05m
売上高(TTM)US$1.10b

1.2x

P/Sレシオ

-60.9x

PER(株価収益率

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
OMCL 損益計算書(TTM)
収益US$1.10b
売上原価US$632.56m
売上総利益US$470.08m
その他の費用US$491.12m
収益-US$21.05m

直近の収益報告

Mar 31, 2024

次回決算日

該当なし

一株当たり利益(EPS)-0.46
グロス・マージン42.63%
純利益率-1.91%
有利子負債/自己資本比率48.0%

OMCL の長期的なパフォーマンスは?

過去の実績と比較を見る